Virios Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Go back to Virios Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Virios Therapeutics (VIRI) Reports Q4 Loss of $1.25/sh

March 18, 2021 7:06 AM EDT

Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($1.25), versus ($0.13) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

... More